MedPath

Intraoperative Case Series Study: Trial Rasp Position Versus SL-PLUS™ MIA Ti/HA Femoral Hip Stem Position

Completed
Conditions
Osteoarthritis
Registration Number
NCT02664272
Lead Sponsor
Smith & Nephew Orthopaedics AG
Brief Summary

A prospective, multicenter, observational study using the SL-PLUS™ MIA Ti/HA femoral hip stem with the appropriate set of instruments.

Detailed Description

The study objective was to evaluate if there was a difference between the femoral position of the last trial rasp and the final implant position of the SL-PLUS™ MIA Ti/HA femoral hip stem. The femoral position of rasp or stem was considered as the height of the implant / rasp in cranio-caudal direction.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Patient:

  • requires primary THA with the SL-PLUS™ MIA Ti/HA femoral hip stem
  • is at least 21 years of age at the time of surgery
  • is skeletally mature in the PI's judgment
  • has consented to participate in the study by signing the EC approved ICF
Exclusion Criteria

Patient:

  • requires the use of a ceramic-on-ceramic bearing
  • has infections, acute or chronic, local or systemic
  • has severe muscle, nerve or vascular diseases that endanger the respective limb
  • has lack of bone substance or defective bone quality that jeopardizes the stable seating of the prosthesis
  • has any concomitant disease that may jeopardize implant function
  • has a known allergy to study device or one or more of its components
  • requires a revision surgery and has extensive bone defects
  • has diagnosis of an immunosuppressive disorder
  • is pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean Difference D Between the Position of the Last Trial Rasp and the Final Implant Position of the SL-PLUS™ MIA Ti/HA Femoral Hip Stem as Measured by an Intraoperative Fluoroscopic MeasurementIntraoperative examination only

Difference D was measured using standardized fluoroscopic images taken during surgery. Investigators also reported any stem position corrections made as well as type of rasping instrument used.

The difference D is given in millimeters (mm) and is defined as D = x1 - x2 with x1 being the distance between the shoulder of the trial rasp and the tip of the greater trochanter and x2 being the distance between the shoulder of the implant and the tip of the greater trochanter.

Secondary Outcome Measures
NameTimeMethod
Number of Hips With Intraoperative ComplicationsIntraoperative examination only

Intraoperative complications were collected as a secondary outcome.

Number of Hips With Leg Length DiscrepancyPreoperative, directly postoperative (approximately 3 months)

Leg length discrepancy was measured preoperatively and postoperatively shortly after insertion of the SL-PLUS™ MIA Ti/HA femoral hip stem.

Trial Locations

Locations (3)

Universitätsklinik für Orthopädie, PMU Salzburg

🇦🇹

Salzburg, Austria

Charité Universitätsmedizin Berlin Centrum für Muskuloskeletale Chirurgie Klinik für Orthopädie

🇩🇪

Berlin, Germany

Orthopädische Chirurgie München

🇩🇪

Munich, Germany

Universitätsklinik für Orthopädie, PMU Salzburg
🇦🇹Salzburg, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.